Table 2.

Characteristics of patients admitted to the hospital versus those who remained outpatient

Characteristicn (%) or Median (IQR)
Outpatient OnlyHospitalized
n28 (68)13 (32)
Men19 (68)11 (85)
Age, yr48 (40–63)56 (43–64)
Time since transplant, mo41 (18–61)43 (15–100)
Deceased donor kidney recipient16 (57)7 (54)
Hypertension25 (89)12 (92)
Diabetes mellitus7 (25)4 (31)
Body mass index, kg/m226.7 (25.0–31.51)26.6 (26.0–34.0)
Angiotensin-converting enzyme inhibitor use2 (7)1 (8)
Angiotensin receptor blocker use3 (11)3 (23)
Baseline serum creatinine, mg/dla1.3 (1.1–1.9)2.0 (1.6–2.8)
Maintenance immunosuppression
 Calcineurin inhibitor21 (75)10 (77)
 Mycophenolate mofetil/mycophenolate sodium23 (82)8 (62)
 Prednisone10 (36)6 (46)
 Azathioprine4 (14)1 (8)
 Belatacept7 (25)2 (15)
Known sick contact17 (61)4 (31)
Symptoms
 Fever21 (75)12 (92)
 Cough18 (64)5 (38)
 Dyspnea (exertional or rest)6 (21)10 (77)
 Gastrointestinal6 (21)5 (38)
 Myalgia/arthralgias10 (36)1 (8)
 Fatigue/malaise6 (21)4 (31)
Seen in clinic for evaluation4 (14)4 (31)
Any reduction in immunosuppression15 (54)11 (84)
Days to symptom improvement, n=2312 (IQR, 8–15; range, 4–23)
Symptom onset to admission, d, n=138 (IQR, 6–9; range, 1–16)
  • IQR, interquartile range.

  • a n=38 due to three patients with missing data.